Protalix BioTherapeutics, Inc. (DE) earnings per share and revenue

PLX earnings per share for the last quarter are -0.05 USD whereas the estimation was 0.08 USD which accounts for -162.50% surprise. Company revenue for the same period amounts to 10.11 M USD despite the estimated figure of 21.60 M USD. Estimated earnings per share for the next quarter are 0.11 USD, and revenue is expected to reach 23.10 M USD. Also watch annual changes over time to get a bigger picture of PLX earnings per share and revenue dynamics.